TNF-alpha binding proteins
- 专利权人:
- AbbVie Inc.
- 发明人:
- Benatuil, Lorenzo,Ghayur, Tariq,Goodreau, Carrie L.,Isakson, Peter C.,Salfeld, Jochen
- 申请号：
- AU2015200579
- 公开号：
- AU2015200579A1
- 申请日:
- 2015.02.06
- 申请国别(地区):
- AU
- 年份:
- 2015
- 代理人:
- 摘要：
- #$%^&*AU2015200579A120150226.pdf#####TNF-ALPHA BINDING PROTEINS ABSTRACT Isolated binding proteins, e.g. antibodies or antigen binding portions thereof, which bind to tumor necrosis factor-alpha (TNF-a), e.g., human TNF-a, and related antibody-based compositions and molecules are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, as well as therapeutic and diagnostic methods for using the antibodies.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- КОМБИНАЦИЯ АНТАГОНИСТА TNF-АЛЬФА И АНТАГОНИСТА VEGF ДЛЯ ПРИМЕНЕНИЯ В ЛЕЧЕНИИ ИЛИ ПРЕДУПРЕЖДЕНИИ ЗАБОЛЕВАНИЙ ГЛАЗ
- Major routes (or human methods and alpha_alpha___) in salts using this combination of beta____or producer and alpha__ lambda__a minerals and TNF activity are used. Lambda - epsilon
- USE OF BENZOPHENONE DERIVATIVE OR SALT THEREOF AND TNF alpha INHIBITOR IN COMBINATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE OR SALT THEREOF AND THE INHIBITOR
- USE OF BENZOPHENONE DERIVATIVE OR SALT THEREOF AND TNFALPHA INHIBITOR IN COMBINATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE OR SALT THEREOF AND THE INHIBITOR
- Use of benzophenone derivative or salt thereof and TNF alpha inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor
